ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan and Sorrento, ImmuneOncia will leverage both companies’ expertise in drug development and antibody engineering. Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide.
ImmuneOncia’s portfolio includes diverse immune checkpoint antibodies; the lead antibody IMC-001 Phase I study was completed in Feb 2019 and its Phase 2 study is being prepared. ImmuneOncia is also developing several antibodies targeting novel immune-checkpoints.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 마곡중앙로 172, Genexin-Progen Bio Innovation Park,6층,korea, Republic Of
- Phone
- +82 (31) 306-8186
- co****@****cia.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.immuneoncia.com
- Keywords
- immuno-oncology, oncology, Biopharmaceutical.
- HQ
- 서울특별시, 강서구
Immuneoncia Therapeutics Inc. Questions
Immuneoncia Therapeutics Inc.'s helpline number is +82 (31) 306-8186
Immuneoncia Therapeutics Inc.'s website is http://www.immuneoncia.com
Immuneoncia Therapeutics Inc.'s LinkedIn profile is https://kr.linkedin.com/company/immuneoncia
Immuneoncia Therapeutics Inc. has
19 employees.
View email and phone details for 19
employees at Immuneoncia Therapeutics Inc..
Immuneoncia Therapeutics Inc.'s industry is
Pharmaceutical Manufacturing
Immuneoncia Therapeutics Inc.'s top competitors are
Orum Therapeutics,
Hanmi Pharmaceutical (한미약품),
Matica Biotechnology, Inc.,
Amc Sciences,
Abion Inc.,
Onconic Therapeutics,
Aptabio,
Yuhan Corporation,
Daehwa Pharmaceutical Co., Ltd.,
Idience.
Immuneoncia Therapeutics Inc.'s support email address is contact@immuneoncia.com
Immuneoncia Therapeutics Inc.'s categories are Pharmaceutical Manufacturing
Immuneoncia Therapeutics Inc.'s founding year is 2016
